Murray Walz

Diagnosed with idiopathic pulmonary fibrosis (IPF) in 2019, Murray took an active approach to their journey with the disease. Knowing there is no cure, they sought out and participated in a clinical trial, driven by a hope to contribute to finding a solution.

Joining the registry was a natural step in their mission to ensure that all IPF patients have access to vital information about new trials, treatments, and potential cures. They are passionate about advocating for research advancements and empowering patients with the knowledge and resources they need to navigate their journey.

Believing in the power of shared experiences, Murray emphasizes the importance of gathering patient stories to help researchers better understand the disease. His dedication to advocacy and collaboration aims to bring hope and progress to the IPF community.